Literature DB >> 8471407

The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin.

J Sahai1, D P Healy, J Stotka, R E Polk.   

Abstract

Six healthy male volunteers participated in a two-period, two-treatment study to determine the effect of chronic calcium carbonate administration on ciprofloxacin bioavailability. There was a mean reduction of 40% in Cmax and 43% in AUC when calcium carbonate was administered with ciprofloxacin, compared with ciprofloxacin alone (P < 0.05). There were no changes in either half-life or tmax. It is therefore recommended that patients being treated with ciprofloxacin for serious infections refrain from ingesting calcium supplements. If this is not possible, administration of ciprofloxacin 2 h before ingestion of the supplement is suggested.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471407      PMCID: PMC1381579     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Effect of staggered dose of calcium on the bioavailability of ciprofloxacin.

Authors:  B M Lomaestro; G R Bailie
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  Interference of dairy products with the absorption of ciprofloxacin.

Authors:  P J Neuvonen; K T Kivistö; P Lehto
Journal:  Clin Pharmacol Ther       Date:  1991-11       Impact factor: 6.875

3.  Ciprofloxacin pharmacokinetics after a standard or high-fat/high-calcium breakfast.

Authors:  R W Frost; J D Carlson; A J Dietz; A Heyd; J T Lettieri
Journal:  J Clin Pharmacol       Date:  1989-10       Impact factor: 3.126

4.  Reduced enteral absorption of ciprofloxacin in the presence of antacids.

Authors:  G Höffken; K Borner; P D Glatzel; P Koeppe; H Lode
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

5.  Liquid-chromatographic determination of ciprofloxacin in serum and urine.

Authors:  D E Nix; J M De Vito; J J Schentag
Journal:  Clin Chem       Date:  1985-05       Impact factor: 8.327

6.  Ciprofloxacin and antacids.

Authors:  L W Fleming; T A Moreland; W K Stewart; A C Scott
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

7.  Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers.

Authors:  R E Polk; D P Healy; J Sahai; L Drwal; E Racht
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

8.  Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin.

Authors:  R W Frost; K C Lasseter; A J Noe; E C Shamblen; J T Lettieri
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

Review 9.  Drug-drug interactions with ciprofloxacin and other fluoroquinolones.

Authors:  R E Polk
Journal:  Am J Med       Date:  1989-11-30       Impact factor: 4.965

  9 in total
  15 in total

1.  Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.

Authors:  H Stass; M F Böttcher; K Ochmann
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 2.  Clinically significant drug interactions with antacids: an update.

Authors:  Ryuichi Ogawa; Hirotoshi Echizen
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

3.  The effect of milk consumption on the pharmacokinetics of fleroxacin and ciprofloxacin in healthy volunteers.

Authors:  J F Hoogkamer; C H Kleinbloesem
Journal:  Drugs       Date:  1995       Impact factor: 9.546

4.  Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin.

Authors:  B A Mueller; D G Brierton; S R Abel; L Bowman
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

5.  Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes.

Authors:  D P Healy; M C Brodbeck; C E Clendening
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

Review 6.  Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly.

Authors:  L R Wiseman; J A Balfour
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

Review 7.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of the phosphate binder lanthanum carbonate.

Authors:  Stephen J P Damment; Michael Pennick
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

9.  Effect of bismuth subsalicylate on ciprofloxacin bioavailability.

Authors:  L Rambout; J Sahai; K Gallicano; L Oliveras; G Garber
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

10.  In vivo interaction between ciprofloxacin hydrochloride and the pulp of unripe plantain (Musa paradisiaca).

Authors:  Nwafor Sv; Esimone Co; Amadi Ca; Nworu Cs
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Oct-Dec       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.